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Abstract 25 
Hyperthyroidism (HyperT) compromises pregnancy and lactation, hindering suckling-induced PRL 26 
release. We studied the effect of HyperT on hypothalamic mRNA (RT-qPCR) and protein (Western 27 
blot) expression of tyrosine hydroxylase (TH), PRL receptor (PRLR) and signaling pathway 28 
members, estrogen-α (ERα) and progesterone (PR) receptors on late pregnancy (days G19, 20 and 29 
21) and early lactation (L2) in rats. HyperT advanced pre-partum PRL release, reduced circulating 30 
PRL on L2 and increased TH mRNA (G21 and L2), p-TH, PRLR mRNA, STAT5 protein (G19 and 31 
L2), PRLR protein (G21) and CIS protein (G19). PRs mRNAs and protein decreased on G19 but 32 
afterwards PRA mRNA (G20), PRB mRNA (G21) and PRA mRNA and protein (L2) increased. 33 
ERα protein increased on G19 and decreased on G20. Thus, the altered hypothalamic PRLR, 34 
STAT5, PR and ERα expression in hyperthyroid rats may induce elevated TH expression and 35 
activation, that consequently, elevate dopaminergic tone during lactation, blunting suckling-induced 36 
PRL release and litter growth. 37 
 38 
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Highlights 40 
• HyperT blocks suckling-induced PRL release and advances the prepartum PRL surge 41 
• HyperT elevated hypothalamic TH mRNA and p-TH on late pregnancy and early lactation 42 
• PRLR, STAT5, CIS, PRA and B also increased on late pregnancy and/or early lactation 43 
• The altered PRL signaling and PRs may induce elevated TH expression and activation 44 
• This elevates dopaminergic tone on lactation, blunting PRL release and litter growth 45 
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List of abbreviatures: 47 
CIS: Cytokine inducible SH2-containing protein. 48 
ERα: Estrogen receptor α. 49 
G19/20/21: Day 19/20/21of pregnancy. 50 
HyperT: hyperthyroidism. 51 
L2: Day 2 of lactation. 52 
MBH: medio basal hypothalamus. 53 
p-TH: phosphorylated Tyrosine hydroxylase. 54 
PR: Progesterone receptor 55 
PRA/PRB: Progesterone receptor isoform A/B. 56 
PRL: Prolactin. 57 
PRLR: Prolactin receptor. 58 
SOCS1/SOCS3: Suppressor of cytokine signaling 1/3 59 
STAT5/STAT5b: Signal transducer activator of transcription 5/5b. 60 
TH: Tyrosine hydroxylase. 61 
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 63 
1. Introduction  64 
Thyroid disorders are common in childbearing age women and are involved in a variety of 65 
reproductive disorders. Female mammals with thyroid dysfunctions show cycle irregularities, sub- 66 
or infertility, abortions and stillbirth (Rosato et al. 1992, Poppe et al. 2007). Two per 1000 pregnant 67 
women have some degree of hyperthyroidism (HyperT). Most of the symptoms of HyperT are 68 
attenuated during pregnancy, but there is a marked recurrence of HyperT after delivery, which has 69 
an adverse effect on development of the offspring (Rodin 1989) Rats made hyperthyroid with high 70 
daily doses of T4 (1 or 0.25 mg/kg/day) display changes in the cycle and in the preovulatory release 71 
of hormones (Jahn et al. 1995). They also display preterm birth caused by premature luteolysis, 72 
increased number of pups, defective parturition, maternal behavior and lactation failure, although 73 
lactogenesis is normal (Rosato et al. 1992). These rats also show an advance in the preterm 74 
prolactin (PRL) surge (Rosato et al. 1992, Rosato et al. 1998, Rosato et al. 2002). Rats treated with 75 
lower doses of T4 (0.1 mg/kg/day) maintain lactation but the litters have a reduced growth rate 76 
caused by a partial blockage of the suckling induced PRL and oxytocin release and premature 77 
mammary gland involution (Varas et al. 2002).  78 
PRL secretion during pregnancy and lactation is subject to complex regulation that involves ovarian 79 
steroids, placental hormones and neurotransmitter systems such as dopaminergic, adrenergic, 80 
serotonergic and opioid, the latter two exerting dual actions (Soaje & Deis 1994, Soaje & Deis 81 
1997, Jahn et al. 1999, Soaje et al. 2004, Valdez et al. 2014). The main regulator of PRL secretion 82 
is dopamine (DA), produced by the tuberoinfundibular dopaminergic (TIDA) and 83 
tuberohypophysial (THDA) neurons located in the arcuate nucleus and the periventricular nucleus 84 
(Freeman et al. 2000). Production of DA by TIDA neurons is regulated by tyrosine hydroxylase 85 
(TH) activity, the rate limiting enzyme for DA biosynthesis (Zigmond et al. 1989). In turn, TH 86 
expression is induced by PRL acting through the long form of its receptor (PRLRlong) that is present 87 
in the dopaminergic neurons and the JAK2-STAT5 signaling pathway (Freeman et al. 2000, Grattan 88 
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2015) conforming the short-loop feedback regulation of PRL release. The transition from pregnancy 89 
to lactation is characterized by considerable changes in circulating hormone levels, mainly a fall in 90 
progesterone (P4) and increased 17β-estradiol (E2) which trigger the prepartum PRL peak, 91 
lactogenesis, delivery and display of maternal behavior (Jahn et al. 1986, Grattan et al. 2008). At 92 
the hypothalamic level there are also changes in the neuronal response, including desensitization of 93 
dopaminergic neurons that allows the maintenance of elevated PRL levels during lactation 94 
(Andrews & Grattan 2004). This decrease in TIDA neurons activity is evidenced at the end of 95 
gestation as a fall in TH expression and DA content (Andrews et al. 2001, Valdez et al. 2007, 96 
Grattan et al. 2008) which seems to be mediated through increased expression of the suppressors of 97 
cytokine signaling (SOCS) family of proteins, which limit PRL signaling, and thus activation of the 98 
short loop feedback (Starr & Hilton 1999, Anderson et al. 2006a, Anderson et al. 2006b, Grattan et 99 
al. 2008). These proteins are induced by PRL and E2 and are elevated during late pregnancy and 100 
lactation in the arcuate neurons (Lee & Voogt 1999, Anderson et al. 2006a, Steyn et al. 2008). 101 
However, this decreased dopaminergic tone is not accompanied with elevated PRL levels until the 102 
prepartum PRL surge triggered by the decrease in circulating P4, indicating a crucial role for this 103 
steroid as an inhibitor of PRL release on late pregnancy (Jahn et al. 1986, Andrews et al. 2001). In 104 
the rat, placental lactogens (PLs) and ovarian steroids are key regulators of PRL secretion during 105 
pregnancy. PLs inhibit pituitary PRL secretion by activation of TIDA neurons (short feedback loop) 106 
and induction of TH expression (Lee & Voogt 1999, Grattan et al. 2008). Estrogens stimulate PRL 107 
secretion, while P4 has a dual action: stimulatory in early pregnancy, but inhibits PRL secretion on 108 
the second half of pregnancy (Jahn et al. 1986).  109 
Both hypothyroidism and HyperT affect PRL secretion in virgin, pregnant and lactating rats (Rosato 110 
et al. 1992, Rosato et al. 1998, Rosato et al. 2002, Hapon et al. 2003, Hapon et al. 2007, Navas et 111 
al. 2011). Usually the effects of thyroid hormones on PRL secretion have been supposed to be 112 
mediated through their actions on TRH, that is a potent PRL stimulating factor (Freeman et al. 113 
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2000). However, it is also possible that some of the effects of thyroid hormones on PRL secretion 114 
may be mediated through direct actions on TIDA neurons, modulating the expression of TH, and/or 115 
receptors for PRL, steroid hormones and neurotransmitters, and the intracellular signaling of these 116 
hormones.  117 
Previous work from our laboratory has shown that (HyperT) and hypothyroidism affect the 118 
concentration of brain neuropeptides that regulate important endocrine and behavioral processes in 119 
reproduction (Ayala et al. 2013). It has also been described that thyroid hormones can modulate 120 
PRLR expression in some tissues (Tiong et al. 1992) and inhibit PRL-induced STAT5a/b nuclear 121 
translocation (Favre-Young et al. 2000). However, there is limited data on their effects on PRLR 122 
expression and activation in hypophysiotropic areas that regulate PRL secretion, for example on 123 
TIDA or THDA neurons. Thyroid hormones could influence PRL secretion through actions on PRL 124 
signaling pathways and TH expression in TIDA and THDA neurons, or through actions on the 125 
expression or activation of receptors for estrogens (ER) or P4 (PR).   126 
To explore further the mechanism whereby HyperT affects PRL secretion and impairs lactation, in 127 
the present work we have studied the effect of chronic treatments with T4 on hypothalamic 128 
expression of TH, PRLR, members of the PRL signaling pathway (STAT5, SOCS, CIS), ER and 129 
PR during late pregnancy and early lactation in rats. 130 
 131 
2. Materials and Methods 132 
2.1. Animals: 133 
Adult female Wistar rats bred in our laboratory, aged 3-4 months, weighing 200-300 g at the onset 134 
of treatment and with regular 4-day cycles were used. Rats were given free access to water and food 135 
and were kept in a light- (lights on from 06:00 h to 20:00 h) and temperature-controlled (22-24ºC) 136 
room. HyperT was induced by daily s.c. injections of T4 (0.25 mg/Kg body weight, dissolved in 0.9 137 
% NaCl alkalinized with NaOH to pH≈9). Control rats were injected with the vehicle. The treatment 138 
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was started on the day of oestrus 8 days before mating and continued until the day of sacrifice. The 139 
presence of spermatozoa in the vaginal smears the morning after caging with a fertile male on the 140 
night of pro-oestrus was considered Day 0 pregnancy. For the groups sacrificed after delivery, the 141 
daily dose of T4 was changed to 0.1 mg/Kg body weight on day 18 of pregnancy, to assure survival 142 
of the pups. Previous work showed that the higher dose provoked 80-90 % pup mortality within 24 143 
h postpartum and a failure of maternal behavior (Rosato et al. 1992, Rosato et al. 1998), while with 144 
the lower dose (Varas et al. 2002), maternal behavior was normal and the pups were able to suckle 145 
(Varas et al. 2002), which allowed for survival of the whole litters.  146 
Groups of 6-10 control or HyperT rats were decapitated on days 19, 20 and 21 of pregnancy and 2 147 
of lactation at 12:00 h. Serum was obtained from trunk blood after centrifugation at 3000 rpm for 20 148 
min and stored at −20º C until E2, P4, PRL, TSH, T3 and total T4 determination by RIA. The brains 149 
were rapidly removed from the skull and immediately placed on an ice-cold stainless steel brain 150 
slicer (RBM 4000C; ASI Instruments, Inc., Warren, Mich., USA) for dissection, in order to obtain 151 
an approximately 2-mm coronal slice including the medio basal hypothalamus (MBH). The MBHs 152 
were dissected from the slice that was within bregma –2.12 to –4.52 mm as determined from optic 153 
chiasm and lateral hypothalamic sulci on the ventral surface of the brain, by making lateral and 154 
oblique cuts along the sides of the third ventricle. The piece of dissected tissue, that includes the 155 
PeN, arcuate nucleus and median eminence and excludes anterior hypothalamic area, ventromedial 156 
nucleus and zona incerta, was frozen on dry ice and stored at –80 ° C until processing (Soaje et al. 157 
2006, Valdez et al. 2007). Animal maintenance and handling was performed according to the NIH 158 
guide for the Care and Use of Laboratory Animals (NIH publication Nº 86-23, revised 1985 and 159 
1991) and the UK requirements for ethics of animal experimentation (Animals Scientific 160 
Procedures, Act 1986). The procedures were approved by the Institutional Animal Care and Use 161 
Committee of the School of Medical Sciences, Universidad Nacional de Cuyo, Mendoza, Argentina 162 
(Protocol approval Nº 17/2012). 163 
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2.2. Hormone determinations 164 
PRL and TSH were measured in all the groups by double antibody radioimmunoassay, using 165 
materials provided by Dr. AF Parlow and the NHPP (National Hormone and Pituitary Program, 166 
Harbor-UCLA Medical Center, Torrance, CA, USA). The hormones were radio-iodinated using the 167 
Chloramine T method and purified by passage through Sephadex G75. The results were expressed 168 
in terms of rat PRL RP-3 or TSH RP-3, standard preparations. Assay sensitivities were less than 0.5 169 
ng/ml serum and the intra-assay coefficient of variation were less than 10%. All the samples were 170 
measured in the same assay in duplicate. 171 
Serum T3, T4, P4 and E2 were measured using commercial kits (Coat-a-Count total T3, total T4, and 172 
Progesterone kits, Siemens, USA and DSL-4800 estradiol kits, Beckman-Coulter, USA). Assay 173 
sensitivities were 7 ng/dl for T3, 0.25 µg/dl for T4, less than 0.02 ng/ml for P4 and 2.2 pg/ml for 174 
estradiol, and the intra-assay coefficients of variation were <10% for all RIAs. All the samples were 175 
measured in the same assay in duplicate. 176 
2.3. Real Time PCR.  177 
MBH samples were homogenized in 0.5 ml of TRIzol (GIBCO-BRL) and total RNA isolated 178 
according to the manufacturer’s instructions. Total RNA concentrations were determined 179 
spectrophotometrically, integrity of the RNA was examined by 1% agarose gel electrophoresis. 180 
First strand cDNA synthesis from 2.5 µg RNA per sample was performed using Moloney murine 181 
leukemia virus retrotranscriptase and random hexamer primers (Invitrogen/Life Technologies, 182 
Buenos Aires, Argentina) in a 20 µl reaction mixture. Real-time quantification was monitored by 183 
measuring the increase in fluorescence caused by the binding of EvaGreen dye (Biotium) to double-184 
strand DNA at the end of each amplification cycle. The cDNAs were amplified with rat-specific 185 
primers for TH, PRLRlong, ERα, total PR and PRB, STAT5b and SOCS1, 3 and CIS in the 186 
conditions described in Supplementary Table 1. Samples were run in duplicate. Simultaneously, 187 
each PCR run included a no-template control and a sample without reverse transcriptase. Real-time 188 
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PCR was performed with a Corbett Rotor Gene 6000 Real-Time Thermocycler (Corbett Research 189 
Pty Ltd (Sydney, Australia) in a final volume of 20 µl. The reaction mixture consisted of 2 µL of 190 
10xPCR Buffer, 1 µL of 50 mM MgCl2, 0.4 µL of 10 mM dNTP Mix (Invitrogen), 1 µL of 20x Eva 191 
Green (Biotium), 0.25 µL of 5 U/µL Taq DNA Polymerase (Invitrogen) 0,1 µL of each 2.5 mM 192 
primer (forward and reverse primers) and 10 µL of diluted cDNA. The PCR reactions were initiated 193 
with 5 min. incubation at 95ºC, followed by 40 cycles of 95ºC for 30 s, 60ºC for 30 s and 72ºC for 194 
30 s. To select the reference gene, we estimated the expression stability of four candidate reference 195 
genes, β-Actin, S16, GAPDH and HPRT1 using the freely available online software BestKeeper 196 
version 1 [http://gene-quantification.com/bestkeeper.html]. This approach allowed us to select S16 197 
as the reference gene since it showed the lowest coefficient between days and treatment groups 198 
compared to β-Actin, GAPDH and HPRT1. Relative levels of mRNA were normalized to S16 199 
reference gene.  Cycle threshold (CT) versus input concentration was plotted and efficiencies for 200 
each primer pair calculated using the equation E=10-1/s-1 where s is the slope. Melt curve analysis 201 
(60 °C–95 °C in 0.2 °C increments) was performed at the end of the amplification and some 202 
samples were subjected to 1.5% agarose gel electrophoresis to examine product purity and verify 203 
correct size for the PCR product. Relative expression was calculated using the 2-∆∆CT method (Livak 204 
& Schmittgen 2001).  205 
2.4. Western blots 206 
For total TH, ERα and PR proteins, the TRIzol protein fractions were prepared according to the 207 
manufacturer instructions from the pellets remaining from RNA preparation and quantified using 208 
the Bradford method. Aliquots of the dissolved fractions containing 8 (for TH) and 20 µg (for the 209 
rest) proteins were separated by 12.5 % SDS-PAGE and electrotransferred to Hybond membranes 210 
as previously described (Bonafede et al. 2011). Samples from control and HyperT from the same 211 
day were processed and run simultaneously. The membranes were probed with anti-PR A+B (1/500 212 
rabbit polyclonal PR130, generated and tested in the Endocrinology and Hormone Dependent 213 
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Tumors Laboratory of the National University of Litoral, Santa Fe, Argentina), and anti-ERα (1/500 214 
rabbit polyclonal antibody sc-7207, Santa Cruz Biotechnology Inc Dallas TX.) using horseradish 215 
peroxidase-conjugated secondary antisera (1/3,000 polyclonal goat anti-rabbit; Dako Cytomation, 216 
Calif., USA), anti-TH (monoclonal mouse anti-TH generously provided by Dr. C. Cuello, McGill 217 
University, Montreal, Canada, 1/500) using horseradish peroxidase-conjugated secondary antisera 218 
(1/3,000 polyclonal goat anti-mouse – Dako Cytomation) and chemiluminescence reagent to detect 219 
specific PR, ERα and TH bands that were quantified by densitometry using NIH Image 1.6/ppc 220 
freeware program. The membranes were stripped and reprobed with anti-α-tubulin (1/12,000 mouse 221 
monoclonal antibody, Sigma, St. Louis, Mo., USA) and horseradish peroxidase-conjugated 222 
secondary antisera (1/3,000 polyclonal goat anti-mouse immunoglobulins, Dako Cytomation) as 223 
loading and transfer control.  224 
For PRLR, STAT5, CIS and p-TH Western blots MBHs were homogenized in 250 ul of 225 
homogenization buffer (50 mM Tris, pH 7.5, 250 mM sucrose, 10 mM benzamidine, 10 mM NaF, 226 
5 mM sodium pyrophosphate, 20 mM glycerophosphate, 1 mM sodium orthovanadate, 1 mM 227 
PMSF, 10 mM p-nitrophenylphosphate, and aprotinin, leupeptin, and pepstatin at 2 mg/l) in an ice 228 
bath. The homogenates were centrifuged at 10,000 g for 30 min and the supernatants separated and 229 
frozen in several aliquots at −20 °C until used. Proteins were quantified using the Bradford method. 230 
Aliquots containing 20 µg proteins from the dissolved fractions were separated by SDS-PAGE and 231 
electrotransferred to Hybond membranes as previously described (Bonafede et al. 2011).  After 232 
rinsing and blocking with BSA 2% the membranes were probed with anti-p-TH (ser-40) (1/500 233 
rabbit polyclonal antibody sc-135715, Santa Cruz Biotechnology Inc.), anti-CIS (H-80): (1/300 234 
rabbit polyclonal antibody sc-15344 Santa Cruz Biotechnology Inc.), STAT5 (c-17) (1/500 rabbit 235 
polyclonal antibody sc-835 Santa Cruz Biotechnology Inc.), anti-PRLR (rabbit monoclonal 236 
antibody EPR7184(2) AbCam) and anti-α-tubulin (1/12,000 mouse monoclonal antibody, Sigma, 237 
St. Louis, Mo., USA) used as a loading and transfer control. 238 
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2.5. Statistical analysis 239 
Statistical analysis was performed using GraphPad Prism, and one or two way ANOVA followed 240 
by the Bonferroni post hoc test to compare any two individual means. When variances were not 241 
homogeneous log transformation of the data was performed. For comparison of two means only, 242 
Student’s t test was used. Differences between means were considered significant at the P < 0.05 243 
level. 244 
 245 
3. Results. 246 
3.1. Effects of HyperT on circulating hormone levels on late pregnancy.  247 
Elevated circulating, T3 and T4 levels and low TSH levels (Supplementary Table 2) in HyperT rats 248 
confirmed the effectiveness of the treatments. The fall in circulating P4 observed on day 21 of 249 
pregnancy (G21) in controls was advanced to G20 in the HyperT rats (Fig. 1B). Concomitantly, 250 
PRL was significantly increased on G21 midday compared with controls and with the previous day 251 
in the HyperT rats (Fig. 1A). These results confirm our previous results (Rosato et al. 1992, Rosato 252 
et al. 1998), where we show that circulating PRL starts to increase on the afternoon of G20 and 253 
continues elevated until midday of G21, decreasing afterwards (Anderson et al. 2006a). In the 254 
control group circulating estradiol levels were similar on the three days while in the HyperT rats, 255 
circulating E2 was significantly lower than controls on G19 and G21, with no differences on G20 256 
(Fig. 1C). There were no significant differences in the weight of control and HyperT rats (not 257 
shown).  258 
 259 
3.2. Effects of HyperT on MBH TH expression on late pregnancy. 260 
To investigate the hypothalamic mechanism by which HyperT modifies the pattern of PRL 261 
secretion between days 19 and 21 of pregnancy, we measured the expression of TH mRNA by 262 
qPCR and total TH and p-TH proteins by Western blot. In control rats, TH mRNA values 263 
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diminished from G19 to G21 (Fig. 2 A). HyperT did not modify the mRNA content of TH on G19 264 
nor G20, but, interestingly, on G21 TH content remained similar to G20, at values that were 265 
significantly higher than controls (Fig. 2A). TH protein also decreased progressively between G19 266 
and 21 in controls. HyperT decreased significantly TH protein at G19 and G20 (Fig. 2B), but at G21 267 
TH expression was significantly increased compared with the previous day (G20), reaching values 268 
similar to controls. In euthyroid rats, p-TH declined from G20 to G21 (Fig. 2C). HyperT increased 269 
significantly p-TH on G19, but values fell on G20, one day earlier than controls, and remained low 270 
on G21 with values similar to controls (Fig. 2C). Thus, the changes in p-TH in each group were 271 
parallel to the decrease in circulating P4 (Fig. 1B). 272 
 273 
3.3. Effects of HyperT on MBH expression of PRLR, STAT5b and members of the SOCS-CIS 274 
family on late pregnancy. 275 
To determine the hypothalamic mechanisms by which HyperT induced changes in TH expression 276 
and activation and thereby on circulating PRL on late pregnancy, we measured the expression of 277 
PRLRlong, STAT5b and members of the SOCS-CIS family mRNA by qPCR and PRLR, STAT5 and 278 
CIS proteins by Western blot.  279 
In control rats, the mRNA contents of PRLRlong, STAT5b SOCS3, SOCS1 and CIS (Fig. 3A) 280 
showed similar patterns of variations with high values in G19 that fell markedly on G20 and G21. 281 
HyperT rats showed a similar pattern with high values on G19 that decreased sharply afterwards. 282 
However, in HyperT rats PRLR mRNA was significantly increased on G19 (Fig. 3A).  283 
In both groups the protein levels of STAT5 decreased from G19 to G20 and remained lower than 284 
G19 thereafter (Fig. 3B), in parallel with changes in PRLR mRNA. Interestingly, in the HyperT 285 
group STAT5 protein levels were significantly higher than controls in G19, fell markedly on G20 286 
and increased on G21 (Fig. 3B). CIS protein levels increased in controls from G19 to G20 and 287 
tended to decrease afterwards to levels that were not different from G19, while in the HyperT group 288 
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CIS was significantly higher at G19 compared with controls and declined afterwards to values 289 
similar to controls (Fig. 3B). We attempted to measure SOCS proteins by Western blot but were not 290 
able to detect them. 291 
 292 
3.4. Effects of HyperT on MBH expression of ER and PR on late pregnancy. 293 
Since P4 and E2 have leading roles in the regulation of PRL, we measured the expression in MBH of 294 
ERα and PR mRNA by real time PCR and of the proteins by Western blot. To calculate the levels 295 
of PRA mRNA we used the method proposed by (Hayashi et al. 2012).  296 
The mRNA content of total PR, PRA and PRB behaved similarly, decreasing abruptly from G19 to 297 
G20 in the control group (Fig. 4A), while in the HyperT group the mRNA content of total PR and 298 
both isoforms were significantly decreased in G19 compared with the controls (Fig. 4A); total PR 299 
and PRA were significantly higher on G20, while PRB mRNA was significantly increased in G21 300 
compared with the controls (Fig. 4A). We were unable to detect PRB protein, but PRA was readily 301 
detectable, and in control rats decreased significantly from G19 to G21. In HyperT rats PRA protein 302 
was significantly lower on G19 and G20 compared with controls (Fig. 4B); however, it tended to 303 
increase from G20 to G21, reaching values that were not different from controls (Fig. 4B).  304 
The level of ERα mRNA in control groups decreased from G19 to G20 (Fig. 4A). In HyperT rats 305 
the mRNA level of ERα tended to be lower than controls in G19 but, following the same pattern as 306 
controls, also decreased afterwards to values that were not different from controls (Fig. 4A). In 307 
contrast with mRNA values, the expression of ERα protein in control rats was similar on all the 308 
days studied (Fig. 4 B). In HyperT rats, ERα protein abundance was significantly higher than 309 
controls on G19, fell to values significantly lower than control in G20 but on G21 the values were 310 
similar to controls, (Fig. 4 B). 311 
 312 
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3.5. Effects of HyperT on circulating hormone levels and MBH expression of TH, PRLR, 313 
STAT5b, members of the SOCS-CIS family, ER and PR on early lactation (L2). 314 
Rats made hyperthyroid with the dose of 0.25 mg/Kg and allowed to deliver showed impaired 315 
maternal behavior and the pups were unable to obtain adequate amounts of milk from their mother, 316 
which caused a mortality of 80-90 % within 24 h confirming previous results (Rosato et al. 1998). 317 
To be able to study the effect of HyperT on lactation we lowered the dose to 0.1 mg/kg from day 18 318 
onwards, a dose that maintains the hyperthyroid state (Supplementary Table 2). This treatment 319 
regimen advanced delivery by approximately 11 h, most control rats delivered on the afternoon (at 320 
18.25 h ± 90 min  of day 22, while HyperT rats delivered in the morning (at 07.50 h ± 130 min of 321 
day 22; mean ± SD, p < 0.0001, Mann Whitney test). HyperT rats also had a significantly increased 322 
number of pups (Controls 10.4 ± 0.4 vs. HyperT 12.9 ± 0.5, p < 0.01, Student’s t test) but allowed 323 
for normal maternal behavior and milk production sufficient for pup survival, confirming previous 324 
results (Rosato et al. 1998, Varas et al. 2002).  325 
T3 and T4 values on L2 in the HyperT rats were lower than values of the pregnancy groups, 326 
reflecting the lower dose administered to these rats from G18 onwards; however, they were still 327 
significantly higher than controls and TSH was significantly lower, indicating that this treatment 328 
regimen was also capable of inducing an hyperthyroid state (Supplementary Table 2). Circulating 329 
PRL levels were significantly lower in L2 HyperT rats compared with controls, while circulating E2 330 
values were not affected by HyperT (Fig. 1).  331 
In controls, MBH TH mRNA and protein contents and p-TH on L2 were similar to the values 332 
observed on G21 (Fig. 2). In HyperT rats, TH mRNA and p-TH levels were significantly increased, 333 
while total TH protein values were similar to controls on L2 (Fig. 2).  334 
In control rats, mRNAs for PRLR, STAT5b, SOCS1, SOCS3 and CIS were significantly increased 335 
when compared with G21, while STAT5 protein was significantly diminished and CIS protein 336 
content was similar to G21 (p < 0.05, ANOVA and Bonferroni post-hoc test, Fig. 3). On L2 HyperT 337 
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increased significantly PRLR mRNA and STAT5 protein levels, while there were no significant 338 
differences on SOCS1, SOCS3 and CIS mRNAs and on CIS protein (Fig. 3). 339 
Total PR and PRA mRNAs decreased significantly in control rats between G21 and L2, while PRB 340 
mRNA PRA protein, ERα mRNA and protein did not change (p < 0.05, one-way ANOVA and 341 
Bonferroni post-hoc test, Fig. 4). On L2, HyperT increased significantly total and PRA mRNA 342 
content, without significant effects on the expression of PRB and ERα mRNAs (Fig. 4). HyperT 343 
increased significantly PRA protein level, while there were no significant differences on ERα 344 
protein (Fig. 4).  345 
 346 
4. Discussion 347 
We have previously shown that HyperT has deleterious effects on lactation, through a partial 348 
blockade in suckling induced PRL release that leads to impaired milk production and release and 349 
stunted litter growth (Varas et al. 2002). The present results confirm our previous findings of low 350 
circulating PRL in HyperT rats during established lactation (days 7 and 14) (Varas et al. 2002) and 351 
extend these results to early lactation (L2). Our findings also confirm the advancement in luteolysis 352 
and prepartum PRL release previously described (Rosato et al. 1992, Navas et al. 2011). 353 
Hypothalamic TH and p-TH expression are good indicators of hypophysiotropic dopaminergic 354 
activity, and show variations that correlate inversely with circulating PRL. In the present work we 355 
explored the mRNA and protein abundance and the phosphorylation state of the TH enzyme as a 356 
marker of its activity. Acting through the JAK2/STAT5 signaling pathway, PRL induces TH 357 
expression and phosphorylation of serine 40 (Grattan et al. 2008). Phosphorylation confers on TH a 358 
greater affinity for its tetrahydrobiopterin cofactor, resulting in an increased rate of dopamine 359 
synthesis (Kumer & Vrana 1996), thus limiting PRL secretion through the short feedback loop 360 
mechanism (Ben-Jonathan et al. 1980, Grattan et al. 2001, Grattan et al. 2008, Brown et al. 2012, 361 
Romano et al. 2013, Grattan 2015). Ovarian steroids, in particular P4 also can modulate TH 362 
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expression and activation through phosphorylation, acting directly upon the expression of TH or 363 
indirectly through modulation of the expression of PRLR and members of the SOCS family, the 364 
latter molecules being the main inhibitors of PRL signaling that counteract the activation of this 365 
pathway (Arbogast & Voogt 1993, Arbogast & Voogt 1996, Jensik & Arbogast 2011). Although P4 366 
acutely inhibits DA synthesis and release (and stimulates PRL secretion) through inactivation of TH 367 
through an increase in its dephosphorylation (Arbogast 2010), it also stimulates TH mRNA and 368 
protein synthesis, so that long term exposure to elevated P4 increases DA synthesis resulting in 369 
inhibition of pituitary PRL release (Jensik & Arbogast 2011). In accordance with previous results 370 
(Wang et al. 1993, Arbogast & Voogt 1996, Fliestra & Voogt 1997, Li et al. 1999, Andrews et al. 371 
2001, Valdez et al. 2007, Feher et al. 2010, Romano et al. 2013), in control rats TH mRNA, protein 372 
and phosphorylated form decreased gradually in the transition from late pregnancy to lactation, 373 
reflecting the establishment of the peripartum damping of the short loop feedback necessary for the 374 
maintenance of hyperprolactinemia during lactation (Wang et al. 1993). Furthermore, p-TH levels 375 
decreased significantly from G20 to G21, in parallel with the fall in circulating P4, a fall that would 376 
promote TH inactivation and the subsequent increase in circulating PRL that is observed on the 377 
afternoon of G21 (Rosato et al. 1992, Valdez et al. 2007, Grattan et al. 2008).  378 
It has been described that circulating levels of T4/T3 modulate brain TH activity by altering kinetic 379 
properties of the enzyme, which in turn influence catecholaminergic activity (Zimmermann et al. 380 
2001, Chaube & Joy 2003). The changes produced by HyperT in circulating PRL can be explained 381 
fairly accurately by the changes in the expression of TH and p-TH. Thus, in parallel with the 382 
changes in P4 levels, a significant fall in p-TH was observed between G19 and G20, one day earlier 383 
than in controls. This fall may be responsible for the increased circulating PRL previously found on 384 
the afternoon of G20 that is still detectable on G21 ((Rosato et al. 1992) and present results), along 385 
with the decrease in total TH protein observed on this day, while on G19, the elevated p-TH may 386 
compensate the low total TH levels maintaining the low circulating PRL levels characteristic of this 387 
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day of pregnancy. The elevated levels of p-TH in HyperT rats on G19 may suggest an elevated 388 
basal hypothalamic TH activity compared with controls. On the other hand, on early lactation (L2), 389 
the elevated p-TH and TH mRNA levels are indicative of maintenance of TH synthesis and 390 
activation, that in turn, suggest an elevated dopaminergic tone that will impair PRL release in 391 
response to suckling. Thus, in HyperT rats the normal postpartum attenuation of the short loop 392 
regulation of PRL secretion seems to be considerably hindered.  393 
At the end of pregnancy in control rats the fall in PRLR and STAT5 mRNAs between G19 and 20 394 
may contribute to the attenuation of the shortloop feedback mechanism, making the cells less 395 
responsive to PRL and/or PLs. This process is necessary for the desensitization of hypothalamic 396 
neuroendocrine dopaminergic neurons to elevated PRL levels, that allows a normal transition to 397 
lactational hyperprolactinemia. Although there was a slight increase on L2, the values continued to 398 
be much lower than on G19, maintaining a decreased responsiveness to PRL during lactation. Thus, 399 
the fall in TH mRNA and protein and in p-TH between G19 and L2 in control rats may be a 400 
consequence of the decreased PRLR and STAT5 expression. In turn, the decrease in the mRNAs of 401 
the members of the SOCS family may also reflect the physiological low responsiveness to PRL, 402 
since they are target genes for PRL but also attenuate the inhibition of PRL signaling produced by 403 
the decreased PRLR and STAT5 (Anderson et al. 2006a, Anderson et al. 2006b). At the end of 404 
pregnancy, PRL has a diminished ability to activate STAT5b (Anderson et al. 2006a), however, in 405 
HyperT rats the PRL signaling pathway seems to be maintained in a more active state, since 406 
PRLRlong mRNA and STAT5 protein were significantly increased in G19 and L2. Furthermore, the 407 
lack of change in the mRNAs of SOCS1, SOCS3 and CIS in HyperT rats on L2, in the presence of 408 
increased PRLR mRNA and STAT5 protein may contribute to the failure to attenuate PRL 409 
signaling in early lactation. Thus, the brain is no exception to the effect of thyroid status on the 410 
expression of PRLR, as seen in other organs such as liver, kidney, adrenal, prostate, mammary 411 
gland and ovary (Tiong et al. 1992). 412 
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The ovarian steroids E2 and P4, are arguably one of the most important regulators of PRL synthesis, 413 
secretion and action in several different physiological states, acting at pituitary and hypothalamic 414 
levels. TIDA neurons express receptors for both (ERα and PR), therefore the steroids can directly 415 
modulate TH expression and PRL signaling (Steyn et al. 2007, Anderson et al. 2008, Steyn et al. 416 
2008), and have been shown to regulate the expression of their cognate receptors as well as of 417 
PRLR in several brain areas (Pi et al. 2003).  The fall in PRA protein and mRNA for total, A and B 418 
PR isoforms from G19 to L2 may be one factor down regulating TH expression and activation in 419 
the control, euthyroid rats. This fall was advanced in HyperT rats, which, along with the early fall in 420 
circulating P4 may participate in the mechanism that induces the premature increase in PRL 421 
secretion seen in the present work on G21 and, since P4 has been shown to inhibit estrogen 422 
induction of PR expression, may be responsible for the subsequent slight increases in the mRNAs 423 
of PRA on G20 and PRB on G21. In contrast, the increased PRA protein seen in HyperT rats on L2, 424 
may contribute to maintain the elevated TH expression and activation during lactation, repressing 425 
PRL secretion. P4 is able to activate the TH promoter acting through both PR isoforms, although 426 
PRB is much more effective (Jensik & Arbogast 2011). Unfortunately we could not detect PRB 427 
protein and thus are unable to ascertain whether it changes in parallel with PRA.  428 
Other authors found stable levels of ERα mRNA (Wagner & Morrell 1995, Mann & Babb 2005) 429 
during pregnancy and early postpartum; our results may confirm these findings, with the exception 430 
of the high levels of ERα mRNA found on G19. However, the previous works did not study this 431 
particular day of pregnancy, which may differ from previous or subsequent days in ER mRNA 432 
expression. We did find constant levels of ERα protein in controls between G19 and L2, that are in 433 
accord with the findings of Steyn et al. (Steyn et al. 2007), who found similar values of ER 434 
immunoractivity in TH+ hypothalamic neurons between G19 and G21, with a significant 435 
diminution only on day 5 of lactation. In contrast, in euthyroid rats we found a steady decrease in 436 
PR mRNA and protein expression between G19 and L2, confirming previous results (Mann & Babb 437 
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2005). Steyn et al. (Steyn et al. 2007) also found decreased PR and ER expression in TH+ cells 438 
between G21 and early lactation. The patterns of PR and ERα expression were disrupted by 439 
HyperT, in particular the protein levels, which along with the changes in circulating P4 and E2, may 440 
account for some of the changes observed in PRL signaling pathway and TH expression.  441 
The changes in ERα and PR expression patterns observed in the HyperT rats may have been caused 442 
by a combination of the hormonal changes observed at the times studied, along with possible direct 443 
actions of thyroid hormones at hypothalamic dopaminergic level. Thus, the fall in PRs mRNAs and 444 
PRA protein observed on G19 in HyperT rats may be a consequence of the low circulating E2 445 
observed on this day, since estrogens induce expression of PR in TH+ arcuate neurons (Steyn et al. 446 
2007). The elevated ERα protein levels observed in HyperT rats may have not been able to 447 
compensate for the low circulating E2. The combination of increased ERα and decreased PRA at 448 
the protein level in HyperT rats on G19 may account for the increased expression of PRLRlong 449 
mRNA and CIS proteins, since it has been shown that E2 stimulate their expression and P4 blocks 450 
the stimulatory action of E2 (Pi et al. 2003, Steyn et al. 2008).  451 
The different patterns of expression of ERα and PRA between mRNA and protein along the days 452 
studied may be due to changes with time of the regulatory mechanisms acting at posttranscriptional 453 
levels that may modulate translation, processing or degradation of the protein (Jacobsen & Horwitz 454 
2012). In turn, HyperT may also have modified these mechanisms, since PRA and ERα proteins 455 
showed patterns markedly different from controls. We have also found co-expression of thyroid 456 
hormone receptors (TRs) and TH in hypothalamic neurons (unpublished results), suggesting that at 457 
least some of the actions on TH expression, receptors and PRL signaling pathway members may be 458 
exerted directly by thyroid hormones on TH+ cells. Furthermore, TRs interact with steroid hormone 459 
receptors at various levels (Freyschuss et al. 1994, Vasudevan et al. 2002, Fujimoto et al. 2004), 460 
modifying their expression and actions. In particular, TRs activation has been shown to increase ER 461 
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levels in liver and in a pituitary cell line (Freyschuss et al. 1994, Fujimoto et al. 2004), and thus 462 
may account for the increased ERα protein levels found in HyperT rats on G19. 463 
In previous works from our laboratory we described that both hyper- and hypothyroidism affect the 464 
content of the neuropeptide NEI, which is involved in cognitive and behavioral responses and in 465 
neuroendocrine function, in discrete brain areas in female and male rats (Ayala et al. 2011, Ayala et 466 
al. 2013). We described differential effects during the estrous cycle where NEI content was affected 467 
by the circulating levels of ovarian steroids (Ayala et al. 2013). More recently we reported that 468 
altered thyroid status affects the interaction between TH+ neurons and fibers and NEI+ neurons in a 469 
specific hypothalamic dopaminergic population of neurons, the A13 group of the 470 
incertohypothalamic area (Ayala et al. 2015). These are further evidences of the impact of thyroid 471 
disturbances in specific brain areas related to neuroendocrine function and its regulation.  472 
The PRLR(long) and steroid hormone receptors are also expressed by non-TH neurons in the ARC, 473 
including KNDy neurons (Kokay et al. 2011) and POMC neurons (Cave et al. 2001, Kokay & 474 
Grattan 2005), and thus, the observed changes could be the summation of the effects on TH neurons 475 
and other populations (POMC or KNDy neurons, etc.) residing in the MBH. However, the most 476 
prevalent neurons in this area are dopaminergic TH+ neurons that also express abundantly PRLR, 477 
ERs and PRs (Kokay & Grattan 2005, Steyn et al. 2007). Furthermore, in Cave et al., 2001 it is 478 
shown that the TH+ neurons are much more responsive to PRL than other PRLR expressing 479 
population, such as POMC neurons. Thus, it is quite probable that the changes observed in the 480 
expression of the members of the PRL signaling pathway take place in the TH+ neurons, especially 481 
on L2 HyperT rats, when we observed elevated STAT5 protein and elevated PRLR mRNA, and that 482 
these variations are responsible for the changes observed in TH expression and activation. We 483 
cannot exclude the possibility that HyperT induces changes in the expression of PRLR, members of 484 
PRL signaling pathways and steroid hormone receptors in other MBH cell populations, that may 485 
affect the overall expression of these genes.  486 
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In conclusion, the changes induced by HyperT in TH expression and activation may explain the 487 
concomitant changes in circulating PRL, such as the premature prepartum increase and the low 488 
levels observed in early lactation. Our findings also may show that the short loop negative feedback 489 
mechanism is constitutively more active in HyperT than in euthyroid rats (Fig. 5), compromising its 490 
physiological attenuation at the end of pregnancy and during lactation and accounting for the deficit 491 
in lactation of HyperT mothers previously described (Rosato et al. 1992, Varas et al. 2002). The 492 
changes observed in the present work at different time points in PRLR, PR and ER expression at 493 
hypothalamic level and the consequent increase in STAT5, contribute to maintain elevated levels of 494 
TH mRNA and p-TH, thus maintaining an increased dopaminergic tone during lactation and 495 
thereby blunting the suckling induced PRL release (Varas et al. 2002).  496 
These findings indicate that HyperT has non-negligible effects at hypothalamic levels that in turn, 497 
compromise lactational performance and the development of the newborn. Although 498 
hyperthyroidism in pregnant women is not frequent, its consequences when not treated adequately 499 
are often severe. The results of the present study may contribute to the management of clinical 500 
hyperthyroidism in the puerperium when the mothers wish to nurse their infant. 501 
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Legends to Figures: 1 
Figure 1: Effect of hyperthyroidism (HyperT, 0.25-0.1 mg/Kg/day s.c. T4, black bars), on 2 
circulating (A) PRL, (B) P4 or (C) E2 concentrations in female rats during days 19, 20, and 21 of 3 
pregnancy (G19, G20, G21) and day 2 of lactation (L2) measured by RIA. Control rats (gray bars) 4 
were injected with saline. See Materials and Methods section for further details. Results are means 5 
± SEM of groups of 8–10 animals in each experimental group. 6 
*p < 0.05 comparing the different groups within the same time point (day). Different superscript 7 
letters represent significant differences at p < 0.05 between the different days of pregnancy or 8 
lactation within the same experimental group, using two-way ANOVA followed by Bonferroni post 9 
hoc test.  10 
Figure 2: Effect of hyperthyroidism (HyperT, 0.25-0.1 mg/Kg/day s.c. T4, black bars), on MBH 11 
content of tyrosine hydroxylase (TH) in female rats on days 19, 20 and 21 of pregnancy (G19, G20, 12 
G21) and day 2 of lactation (L2). Control rats (gray bars) were injected with saline. mRNA levels 13 
were measured by real time RT-PCR on samples of MBH total RNA and protein levels by Western 14 
blot. The graphs may have different scales. See Materials and Methods section for further details. 15 
(A) TH mRNA expression; (B) Total TH protein expression; (C) p-TH protein expression. Each 16 
column represents mean ± SEM of groups of 6-8 rats. 17 
*p < 0.05 comparing the different groups within the same time point (day). Different superscript 18 
letters represent significant differences at p < 0.05 between the different days of pregnancy or 19 
lactation within the same experimental group, using two-way ANOVA followed by Bonferroni post 20 
hoc test. 21 
Figure 3: Effect of hyperthyroidism (HyperT, 0.25- 0.1 mg/Kg/day s.c. T4, black bars), on MBH 22 
content of PRLRLong; STAT5b; CIS, SOCS1 and SOCS3 mRNAs (A) and  STAT5 and CIS proteins 23 
(B) in female rats on days 19, 20 and 21 of pregnancy (G19, G20, G21) and day 2 of lactation (L2). 24 
Control rats (gray bars) were injected with saline. mRNA levels were measured by real time RT-25 
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PCR on samples of MBH total RNA and protein levels by Western blot. The graphs may have 1 
different scales. See Materials and Methods section for further details.  Each column represents 2 
mean ± SEM of groups of 6-8 rats.  3 
*p < 0.05 comparing the different groups within the same time point (day). Different superscript 4 
letters represent significant differences at p < 0.05 between the different days of pregnancy or 5 
lactation within the same experimental group, using two-way ANOVA followed by Bonferroni post 6 
hoc test. 7 
Figure 4: Effect of hyperthyroidism (HyperT, 0.25 mg/Kg/day s.c. T4, black bars), on MBH content 8 
of total PR, PRA, PRB and ERα mRNA (A) and PRA and ERα protein (B) in female rats on days 9 
19, 20 and 21 of pregnancy (G19, G20, G21) and day 2 of lactation (L2). Control rats (gray bars) 10 
were injected with saline. mRNA levels were measured by real time RT-PCR on samples of MBH 11 
total RNA and protein levels by Western blot. The graphs may have different scales. See Materials 12 
and Methods section for further details. Each column represents mean ± SEM of groups of 6-8 rats.  13 
*p < 0.05 comparing the different groups within the same time point (day). Different superscript 14 
letters represent significant differences at p < 0.05 between different days of pregnancy or lactations 15 
of the same experimental group.  16 
Figure 5: Model of the proposed changes in the regulation of PRL secretion at the end of 17 
pregnancy and early lactation in euthyroid and HyperT rats. Panel A: representative scheme of 18 
circulating hormones (PRL and P4); Panel B: representative changes in hypothalamic dopaminergic 19 
activity and the short loop feedback  (SLF). In control euthyroid rats, during late pregnancy (G19) 20 
SLF is active, with high expression of the members of the PRLR/JAK/STAT5 signaling pathway 21 
(which change in parallel with the SLF, not shown in the figure) that maintain high TH activity and 22 
expression and low PRL levels. In addition, high levels of P4 contribute to maintain elevated TH 23 
expression and activity. In euthyroid conditions, as delivery approaches, the short loop negative 24 
feedback mechanism begins to attenuate, as shown by the decreases in the expression of TH, PRLR 25 
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and STAT5, but elevated P4 maintains p-TH at high levels and low circulating PRL. When P4 falls 1 
in G21, p-TH decreases and initiates the prepartum PRL surge. In the postpartum, P4 and PRs are 2 
low and the short loop feedback continues to attenuate (with low PRLR and STAT5 expression and 3 
increases in SOCS and CIS mRNAs), enabling high PRL release induced by suckling.  4 
In HyperT rats, the short loop negative feedback mechanism seems to be constitutively more active 5 
than in euthyroid rats, evidenced by high PRLR, STAT5 and p-TH on G19 and in the postpartum. 6 
However, the premature luteolysis and fall in P4 induces an advancement in the fall in total TH, p-7 
TH and in the PRL surge. However, on G21 and after delivery, the short loop negative feedback 8 
mechanism seems to be less attenuated, as evidenced by the increases in PRLR protein on G21 and 9 
PRLR mRNA,  and STAT5 protein on L2, without  significant changes in SOCS and CIS mRNAs, 10 
that in turn results in elevated p-TH and TH mRNA and, as a consequence low serum PRL levels. 11 
 12 
 13 
 14 
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Highlights 
• HyperT blocks suckling-induced PRL release and advances the prepartum PRL surge 
• HyperT elevated hypothalamic TOH mRNA and p-TOH on late pregnancy and early lactation 
• PRLR, STAT5, CIS, PRA and B also increased on late pregnancy and/or early lactation 
• The altered PRL signaling and PRs may induce elevated TOH expression and activation 
• This elevates dopaminergic tone on lactation, blunting PRL release and litter growth 
 
